Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

ChatGPT Health fails critical emergency and suicide safety tests

24

Feb 2026

ChatGPT Health fails critical emergency and suicide safety tests

ChatGPT Health, a widely used consumer artificial intelligence (AI) tool that provides health guidance directly to the public-including advice about how urgently to seek medical care-may fail to direct users appropriately to emergency care in a significant number of serious cases, according to researchers at the Icahn School of Medicine at Mount Sinai.

Indoor plants help create healthier, more climate-resilient buildings

24

Feb 2026

Indoor plants help create healthier, more climate-resilient buildings

Houseplants and more advanced plant systems, such as indoor living walls and hydroponic towers, have the potential to raise indoor humidity, boost thermal comfort and help create healthier, more climate-resilient buildings, according to new research led by the University of Surrey's Global Centre for Clean Air Research.

Attacks on healthcare surge in Ukraine

24

Feb 2026

Attacks on healthcare surge in Ukraine

As Ukraine enters the fifth year of full-scale war, its people have endured the highest number of attacks on their health care in 2025 – increasing by nearly 20% compared to 2024.

Danaher to acquire Masimo Corporation

24

Feb 2026

Danaher to acquire Masimo Corporation

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.